HOME WEB NEWS IMAGES CLASSIFIEDS YELLOW PAGESPOLLS - SURVEYS WIKI COUNTRIES PHOTOS US UK INDIA
Avoo.com provides meta search results from various sources

Imiquimod


Google




Imiquimod

Systematic (IUPAC) name
1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
Identifiers
CAS number 99011-02-6
ATC code D06BB10
PubChem 57469
DrugBank APRD01030
Chemical data
Formula C14H16N4 
Mol. mass 240.304 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 20 hours (topical dose), 2 hours (subcutaneous dose)
Excretion  ?
Therapeutic considerations
Licence data

EUUS

Pregnancy cat.

B1(AU) C(US)

Legal status

POM(UK) -only(US)

Routes Topical

Imiquimod (INN) is a prescription medication that acts as an immune response modifier. It is marketed by MEDA AB, Graceway Pharmaceuticals and iNova Pharmaceuticals under the trade name Aldara and by Mochida as Beselna.

Contents

Uses

Imiquimod is a patient-applied cream used to treat certain diseases of the skin, including skin cancers (basal cell carcinoma, Bowen\'s diseasevan Egmond S, Hoedemaker C, Sinclair R (2007). "Successful treatment of perianal Bowen\'s disease with imiquimod". Int J Dermatol 46 (3): 318-9. PMID 17343595., superficial squamous cell carcinoma, some superficial malignant melanomas, and actinic keratosis) as well as genital warts (Condylomata acuminata). It has also been tested for treatment of Molluscum contagiosum and VAIN (vaginal intraepithelial neoplasia).Buck HW, Guth KJ. "Treatment of vaginal intraepithelial neoplasia (primarily low grade) with imiquimod 5% cream.". J Low Genit Tract Dis. PMID 17051086.

History

The original FDA approval was on February 27, 1997, FDA Application No. (NDA) 020723, by Graceway.

Since then, the label has been revised many times. Adverse side effects have been reported, in some cases serious and systemic.

Mechanism of action

The exact mechanism of action in which imiquimod and its analogs activate the immune system is not yet known. Nevertheless, it is known that imiquimod activates immune cells by ligating the toll-like receptor 7 (TLR7), commonly involved in pathogen recognition, on the cell surface.Hemmi, H., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol.. 2002 3(2):196-200. PMID 11812998. Cells activated by imiquimod via TLR-7 secrete cytokines (primarily interferon-α (IFN-α), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)). Sauder, D.N., Imiquimod: modes of action. British Journal of Dermatology. 2003 149(Suppl. 66):5-8. PMID 14616337 There is evidence that imiquimod, when applied to skin, can lead to the activation of Langerhans cells, which subsequently migrates to local lymph nodes to activate the adaptive immune system.Miller, R.L., et al. Imiquimod applied topically: a novel immune response modifier and a new class of drug. Int J Immunopharmacol. 1999 Jan;21(1):1-14. PMID 10411278 Other cell types activated by imiquimod include natural killer cells, macrophages and B-lymphocytes.

References

External links

 This antimicrobial-related article is a stub. You can help Wikipedia by expanding it.

This article is licensed under the GNU Free Documentation License. It uses material from Wikipedia


Advertise with Us | Search Marketing | Help | Suggest a Site | Privacy Policy
© 2008 www.avoo.com. All rights reserved.